197 related articles for article (PubMed ID: 31625954)
1. Efficacy, Patient-Reported Outcomes, and Safety for Millennial Subjects Treated With OnabotulinumtoxinA for Moderate to Severe Horizontal Forehead Lines.
Palm MD; Few J; Patel T; Safa M; Drinkwater A; Mao C; Garcia JK
Dermatol Surg; 2020 May; 46(5):653-661. PubMed ID: 31625954
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, Patient-Reported Outcomes, and Safety in Male Subjects Treated With OnabotulinumtoxinA for Improvement of Moderate to Severe Horizontal Forehead Lines.
Keaney TC; Cavallini M; Leys C; Rossi A; Drinkwater A; Manson Brown S; Garcia JK; Mao C
Dermatol Surg; 2020 Feb; 46(2):229-239. PubMed ID: 31343446
[TBL] [Abstract][Full Text] [Related]
3. Safety, Efficacy, and Patient Satisfaction With OnabotulinumtoxinA for the Treatment of Upper Facial Lines in Japanese Subjects.
Kawashima M; Harii K; Horiuchi Y; Seidman E; Lei X; Hopfinger R; Lee E
Dermatol Surg; 2020 Apr; 46(4):483-490. PubMed ID: 31517663
[TBL] [Abstract][Full Text] [Related]
4. OnabotulinumtoxinA for Treatment of Forehead and Glabellar Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Double-Blind Study.
Ogilvie P; Rivkin AZ; Dayan S; Yoelin SG; Weichman BM; Garcia JK
Dermatol Surg; 2019 May; 45(5):689-699. PubMed ID: 31034447
[TBL] [Abstract][Full Text] [Related]
5. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Repeated OnabotulinumtoxinA Treatments in Subjects With Crow's Feet Lines and Glabellar Lines.
Carruthers J; Rivkin A; Donofrio L; Bertucci V; Somogyi C; Lei X; Davis PG; Campo A; Beddingfield FC
Dermatol Surg; 2015 Jun; 41(6):702-11. PubMed ID: 25993609
[TBL] [Abstract][Full Text] [Related]
6. Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines.
De Boulle K; Werschler WP; Gold MH; Bruce S; Sattler G; Ogilvie P; Street J; Larsen KE; Yushmanova I; Lei X; Lee E; Vitarella D; Mao C
Dermatol Surg; 2018 Nov; 44(11):1437-1448. PubMed ID: 30096106
[TBL] [Abstract][Full Text] [Related]
7. OnabotulinumtoxinA for Simultaneous Treatment of Upper Facial Lines: Subject-Reported Satisfaction and Impact From a Phase 3 Study.
Rivkin AZ; Ogilvie P; Dayan S; Yoelin SG; Weichman BM; Garcia JK
Dermatol Surg; 2020 Jan; 46(1):50-60. PubMed ID: 30829771
[TBL] [Abstract][Full Text] [Related]
8. Self-perception of natural outcome, appearance, and emotional well-being after OnabotulinumtoxinA treatment for upper facial lines: Post hoc analysis across age and gender.
Dayan S; Ogilvie P; Boyd C; De Boulle K; Cavallini M; Garcia JK; Musumeci M
J Cosmet Dermatol; 2024 Jan; 23(1):107-116. PubMed ID: 37616390
[TBL] [Abstract][Full Text] [Related]
9. High Patient Satisfaction for up to 6 Months With OnabotulinumtoxinA Treatment for Upper Facial Lines.
Cohen JL; Fagien S; Ogilvie P; De Boulle K; Carruthers J; Cox SE; Kelly R; Garcia JK; Sangha S
Dermatol Surg; 2022 Nov; 48(11):1191-1197. PubMed ID: 36342250
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of OnabotulinumtoxinA Treatment of Forehead Lines: A Multicenter, Randomized, Dose-Ranging Controlled Trial.
Solish N; Rivers JK; Humphrey S; Muhn C; Somogyi C; Lei X; Bhogal M; Caulkins C
Dermatol Surg; 2016 Mar; 42(3):410-9. PubMed ID: 26863598
[TBL] [Abstract][Full Text] [Related]
11. OnabotulinumtoxinA (Botox) in the Treatment of Crow's Feet Lines in Japanese Subjects.
Harii K; Kawashima M; Furuyama N; Lei X; Hopfinger R; Lee E
Aesthetic Plast Surg; 2017 Oct; 41(5):1186-1197. PubMed ID: 28733805
[TBL] [Abstract][Full Text] [Related]
12. Pooled Subject-Reported Outcomes From 2 Phase 3 Studies of OnabotulinumtoxinA for Simultaneous Treatment of Forehead and Glabellar Lines.
Ogilvie P; Rivkin AZ; Dayan S; Yoelin SG; Larsen KE; Varon S; Garcia JK
Dermatol Surg; 2020 Jul; 46(7):950-957. PubMed ID: 31567611
[TBL] [Abstract][Full Text] [Related]
13. Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure.
Rivers JK; Bertucci V; McGillivray W; Muhn C; Rosen N; Solish N; Weichman BM; Wheeler S; Daniels SR; Gallagher CJ
Dermatol Surg; 2015 Aug; 41(8):950-9. PubMed ID: 26218728
[TBL] [Abstract][Full Text] [Related]
14. Evolution of Facial Aesthetic Treatment Over Five or More Years: A Retrospective Cross-sectional Analysis of Continuous OnabotulinumtoxinA Treatment.
Carruthers A; Sadick N; Brandt F; Trindade de Almeida AR; Fagien S; Goodman GJ; Raspaldo H; Smith K; Darmody S; Gallagher CJ; Street J; Romagnano L
Dermatol Surg; 2015 Jun; 41(6):693-701. PubMed ID: 25973559
[TBL] [Abstract][Full Text] [Related]
15. Treatment of crow's feet lines and forehead lines with Botox (onabotulinumtoxinA): Development, insights, and impact.
Carruthers A; Carruthers J; De Boulle K; Lowe N; Lee E; Brin MF
Medicine (Baltimore); 2023 Jul; 102(S1):e32496. PubMed ID: 37499083
[TBL] [Abstract][Full Text] [Related]
16. OnabotulinumtoxinA and Hyaluronic Acid in Facial Wrinkles and Folds: A Prospective, Open-Label Comparison.
Cohen JL; Swift A; Solish N; Fagien S; Glaser DA
Aesthet Surg J; 2019 Jan; 39(2):187-200. PubMed ID: 29762642
[TBL] [Abstract][Full Text] [Related]
17. Forehead Line Treatment With OnabotulinumtoxinA in Subjects With Forehead and Glabellar Facial Rhytids: A Phase 3 Study.
Fagien S; Cohen JL; Coleman W; Monheit G; Carruthers J; Street J; Larsen KE; Yushmanova I; Lei X; Lee E; Vitarella D; Mao C
Dermatol Surg; 2017 Dec; 43 Suppl 3():S274-S284. PubMed ID: 33065953
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial.
Carruthers A; Bruce S; de Coninck A; Connolly S; Cox SE; Davis PG; Campo A; Lei X; Somogyi C; Lee E; McLean H; Beddingfield F
Dermatol Surg; 2014 Nov; 40(11):1181-90. PubMed ID: 25347451
[TBL] [Abstract][Full Text] [Related]
19. OnabotulinumtoxinA Treatment for Moderate to Severe Forehead Lines: A Review.
De Boulle K; Carruthers A; Solish N; Carruthers J; Phillipp-Dormston WG; Fagien S; Sangha S; Silberberg M; Mao C
Plast Reconstr Surg Glob Open; 2020 Mar; 8(3):e2669. PubMed ID: 32537333
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crow's Feet: A Phase 3, Multicenter, Randomized, Double-Blind, Split-Face Study.
Cheon HI; Jung N; Won CH; Kim BJ; Lee YW
Dermatol Surg; 2019 Dec; 45(12):1610-1619. PubMed ID: 30893169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
